{"DataElement":{"publicId":"3436563","version":"2","preferredName":"Prostate Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","preferredDefinition":"Extent of the primary prostate carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2188818v1.0:3436530v1.1","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188818","version":"1","preferredName":"Prostate Tumor Pathologic T Stage","preferredDefinition":"Information related to pathologic T stage for prostate tumor.","longName":"PRS_TUMOR_P_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E56816DF-3F94-5257-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3436530","version":"1.1","preferredName":"Prostate Cancer American Joint Committee on Cancer Edition 7 Pathologic T Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3436530v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"Prostate Cancer cT0 TNM Finding v7","ValueMeaning":{"publicId":"3436514","version":"1","preferredName":"Prostate Cancer cT0 TNM Finding v7","longName":"3436514","preferredDefinition":"No evidence of primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT0 TNM Finding v7","conceptCode":"C89209","definition":"No evidence of primary tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-46BC-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B762-90BE-E040-BB89AD433DCB","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT2a","valueDescription":"Prostate Cancer pT2a TNM Finding","ValueMeaning":{"publicId":"2833289","version":"1","preferredName":"Prostate Cancer pT2a TNM Finding","longName":"2833289","preferredDefinition":"Prostate cancer limited to one-half or less of one lobe of the prostate gland. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT2a TNM Finding v6 and v7","conceptCode":"C48237","definition":"Prostate cancer limited to one-half or less of one lobe of the prostate gland. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621F0959-1BA9-56E5-E040-BB89AD435D85","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B853-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"Prostate Cancer pT2b TNM Finding","ValueMeaning":{"publicId":"2833329","version":"1","preferredName":"Prostate Cancer pT2b TNM Finding","longName":"2833329","preferredDefinition":"Prostate cancer involving more than one-half of one lobe, but not both lobes of the prostate gland. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT2b TNM Finding v6 and v7","conceptCode":"C48238","definition":"Prostate cancer involving more than one-half of one lobe, but not both lobes of the prostate gland. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621F0959-1C26-56E5-E040-BB89AD435D85","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B867-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT2","valueDescription":"Prostate Cancer pT2 TNM Finding","ValueMeaning":{"publicId":"2833291","version":"1","preferredName":"Prostate Cancer pT2 TNM Finding","longName":"2833291","preferredDefinition":"Prostate cancer confined to the prostate gland. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT2 TNM Finding v6 and v7","conceptCode":"C48236","definition":"Prostate cancer confined to the prostate gland. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621F0959-1BCF-56E5-E040-BB89AD435D85","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B83F-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT2c","valueDescription":"Prostate Cancer pT2c TNM Finding","ValueMeaning":{"publicId":"2833327","version":"1","preferredName":"Prostate Cancer pT2c TNM Finding","longName":"2833327","preferredDefinition":"Prostate cancer involving both lobes of the prostate gland. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT2c TNM Finding v6 and v7","conceptCode":"C48239","definition":"Prostate cancer involving both lobes of the prostate gland. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621F0959-1C00-56E5-E040-BB89AD435D85","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B87B-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT3","valueDescription":"Prostate Cancer pT3 TNM Finding","ValueMeaning":{"publicId":"3436532","version":"1","preferredName":"Prostate Cancer pT3 TNM Finding","longName":"3436532","preferredDefinition":"Prostate cancer with extraprostatic extension. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3 TNM Finding v6 and v7","conceptCode":"C48240","definition":"Prostate cancer with extraprostatic extension. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4956-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B88F-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"Prostate Cancer pT3a TNM Finding v7","ValueMeaning":{"publicId":"3351842","version":"1","preferredName":"Prostate Cancer pT3a TNM Finding v7","longName":"3351842","preferredDefinition":"Prostate cancer with extraprostatic extension or microscopic invasion of bladder neck.  Positive surgical margin should be indicated by an R1 descriptor (residual microscopic disease). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3a TNM Finding v7","conceptCode":"C89202","definition":"Prostate cancer with extraprostatic extension or microscopic invasion of bladder neck.  Positive surgical margin should be indicated by an R1 descriptor (residual microscopic disease). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B66D065F-17A4-4C96-E040-BB89AD437AF5","latestVersionIndicator":"Yes","beginDate":"2012-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B8A3-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"Prostate Cancer pT3b TNM Finding","ValueMeaning":{"publicId":"2833389","version":"1","preferredName":"Prostate Cancer pT3b TNM Finding","longName":"2833389","preferredDefinition":"Prostate cancer extending beyond the capsule of the prostate gland, with involvement of the seminal vesicles. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT3b TNM Finding v6 and v7","conceptCode":"C48242","definition":"Prostate cancer with seminal vesicle invasion. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621F0959-1C73-56E5-E040-BB89AD435D85","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B8B7-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pT4","valueDescription":"Prostate Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"3436531","version":"1","preferredName":"Prostate Cancer pT4 TNM Finding v7","longName":"3436531","preferredDefinition":"Prostate cancer with tumor invading the rectum, levator muscles, and/or pelvic wall. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pT4 TNM Finding v7","conceptCode":"C89203","definition":"Prostate cancer with tumor invading the rectum, levator muscles, and/or pelvic wall. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-48DF-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B8CB-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"TX","valueDescription":"Prostate Cancer cTX TNM Finding v7","ValueMeaning":{"publicId":"3351730","version":"1","preferredName":"Prostate Cancer cTX TNM Finding v7","longName":"3351730","preferredDefinition":"Primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cTX TNM Finding v7","conceptCode":"C89208","definition":"Primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65BB4F3-604D-218B-E040-BB89AD4337DD","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-B758-90BE-E040-BB89AD433DCB","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3436529","version":"1","preferredName":"Prostate Cancer Pathologic TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89200:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Pathologic TNM Finding v7","conceptCode":"C89200","definition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-48B6-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D69227DB-B741-90BE-E040-BB89AD433DCB","latestVersionIndicator":"Yes","beginDate":"2013-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"COOPERM","dateModified":"2013-02-25","changeDescription":"Versioned to increase max length from 3 to 4.  Added 2 PVs, TX and T0 and changed PVs to add \"p\" in front of \"T\".  mc 2/25/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000013","version":"1","longName":"Prostate","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855643","version":"1","longName":"Prostate Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000014","version":"1","longName":"Prostate","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"PROS_PATH_TSTAGE_AJCC7","type":"Context Short Name","context":"CTEP"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"ajcc_7_prostate_pathologic_t","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"NCI Standards"},{"name":"MCL Path-1","type":"Alternate Question Text","description":"Pathological- T","url":null,"context":"MCL"},{"name":"MCL-PCA-prostate-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer tumor stage code","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"D6924AAB-657B-5AF2-E040-BB89AD434116","latestVersionIndicator":"Yes","beginDate":"2013-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"COLBERTM","dateModified":"2021-09-22","changeDescription":"9/22/21 mr Added alt name, AQT, alt def, ref doc, CSI PCA prostate. Per MCL DD.   Created for CRF standard harmonization. Released per final community approval. mc 5/7/12 Versioned to associate with new version of VD. mc 2/25/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}